Tyrosine Kinases as Druggable Targets in Cancer
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...
Wedi'i Gadw mewn:
| Awduron Eraill: | |
|---|---|
| Fformat: | Electronig Pennod Llyfr |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
IntechOpen
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | DOAB: download the publication DOAB: description of the publication |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Byddwch y cyntaf i adael sylw!